Clinical outcomes and prognostic biomarkers among pregnant, post-partum and nulliparous women with breast cancer: a prospective cohort study.

Katarzyna J JerzakNechama LiptonSharon Nofech-MozesDina BolesElzbieta SlodkowskaGregory R PondEllen Warner

Published in: Breast cancer research and treatment (2021)

PPBC patients had numerically lower DFS and OS compared to NP controls. Higher PDL1 and stromal TILs in PPBC suggest that adjuvant immunotherapy may be effective in the post-partum BC subgroup.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
pregnant women
early stage
prognostic factors
bone marrow
peritoneal dialysis
randomized controlled trial